Press release
North America Autologous Cell Therapy Market Growth Outlook Report 2027
Autologous Cell Therapy Market: OverviewAccording to Transparency Market Research's latest report on the global autologous cell therapy market for the historical period 2017-2018and forecast period 2019-2027, Rise in prevalence of rEdisorders, cancer, blood related disorders, are projected to drive the global autologous cell therapy market during the forecast period.
According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in2018 and is anticipated to expand at a CAGR of1% from 2019 to 2027
Read Report Overview@
https://www.transparencymarketresearch.com/autologus-cell-therapy-market.html
Rise in Prevalence of Autoimmune Disorders, Cancer, Neurodegenerative Disease Increase the Demand of Autologous cell therapy: Key Drivers
The global autologous cell therapy market continues to expand at a high growth rate due to increasing prevalence of autoimmune diseases, cancer orthopedic disorders. According to AARDA (American Autoimmune Related Diseases Association), around 50 Mnpeople in U.S. suffering from autoimmune diseases and this number is expected to rise in the future. In addition increasing use of autologous cell therapy in the treatment of several conditions such as neurological, orthopedic, oncology, and a wide range of autoimmune diseases. Is likely to drive the growth of this market during forecasted period.
According to American Cancer Society,1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States in.
According to The Parkinson's Foundation, Currently more than 10 millionpeople worldwide are living with Parkinson's disease (PD).
Get Sample Copy of the Report@
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715
Strong Product Pipeline and Increasing Government Support Boost Market Growth
Major manufacturers are focusing on research and development activity for new autologous cell therapy products. Currently TESSA Therapeutics has innovative autologous cell therapy product (TT12) in pipeline i.e. Phase 1 for treatment of HPV-Associated Cancers. Strong product pipeline is helps to drive the growth of this market.
Increasing government support and funding is likely to drive the growth of this market during forecasted period. National Institute of Health (NIH) had spent around US$ 2 Bnfor stem cells research in the U.S. in
Government regulations against unethical harvesting of stem cells and lack of reimbursement in emerging countries to hamper market
Reproductive cloning is banned in U.S. European nations such as Germany, Austria, Portugal and Italy and some Asian nations such as China, South Korea and Israel. However, therapeutic cloning is permitted. The restrictions on research activities had hampered the growth of stem cells and thereby restricting the demand for autologous cell therapy products.
Reimbursements are provided by various governments and private insurance agencies to meet the needs of several patient undergo cell therapy(autologous) treatment. However, lack of reimbursement policies in various less developed and emerging economies for treatment with the help of cell therapy and high cost of treatment restrain the market
Enquiry Before Buying@ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=715
Global Autologous cell therapy Market: Competitive Landscape
This report profiles major players in the global autologous cell therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global autologous cell therapy market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global autologous cell therapy market are
Pharmicell Co., Inc.
Castle Creek Biosciences, Inc.
Vericel Corporation
Lineage Cell Therapeutics, Inc.
BrainStorm Cell Therapeutics
Caladrius Biosciences, Inc.
Opexa Therapeutics, Inc.
Regeneus Ltd.
Takeda Pharmaceutical Company Limited.
Sangamo Therapeutics
U.S. Stem Cell, Inc
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Autologous Cell Therapy Market Growth Outlook Report 2027 here
News-ID: 2790111 • Views: …
More Releases from Transparency Market Research
Soy and Milk Protein Ingredients Market to Reach USD 67.0 Billion by 2036 Amid R …
The global Soy and Milk Protein Ingredients Market is witnessing significant momentum as consumers increasingly prioritize high-protein diets, functional nutrition, and clean-label ingredients. With the surge in plant-based alternatives, sports nutrition products, and fortified food offerings, soy and milk protein ingredients have become critical components across multiple industries including food & beverages, pharmaceuticals, animal nutrition, and personal care.
The global Soy and Milk Protein Ingredients Market is projected to reach US$…
Electric Vehicle Adhesives Market to Reach US$ 9.5 Bn by 2036, Expanding at 12.3 …
The global electric vehicle (EV) adhesives market was valued at US$ 2.7 Bn in 2025 and is projected to reach US$ 9.5 Bn by 2036, expanding at a robust CAGR of 12.3% from 2026 to 2036. The market is witnessing significant growth driven by accelerating electric vehicle adoption, increasing demand for lightweight materials, rapid battery technology advancements, and stricter emission regulations worldwide.
Electric vehicle adhesives are specialized bonding solutions used in…
Biostimulants Market to Reach US$ 99.5 Bn by 2036 Amid Rising Demand for Sustain …
The global biostimulants market is entering a transformative growth phase as agriculture shifts toward sustainability, productivity, and environmental stewardship. Valued at US$ 36.3 Bn in 2025, the market is projected to reach US$ 99.5 Bn by 2036, expanding at a robust CAGR of 9.6% from 2026 to 2036. The surge in demand for sustainable agricultural solutions, coupled with growing consumer preference for organic products, is fueling widespread adoption of biostimulants…
Carbon Fiber Market to Reach US$ 6.7 Bn by 2036, Driven by Surging Demand for Li …
The global carbon fiber market is poised for substantial expansion over the next decade, driven by the increasing adoption of lightweight, high-strength materials across automotive, aerospace, wind energy, and electric vehicle applications. According to recent industry analysis, the market was valued at US$ 3.2 Bn in 2025 and is projected to reach US$ 6.7 Bn by 2036, expanding at a CAGR of 6.8% from 2026 to 2036.
Access key findings and…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
